These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23313929)

  • 21. The mysterious cognitive disorder of Parkinson disease.
    Mortimer JA
    Alzheimer Dis Assoc Disord; 1990; 4(3):129-32. PubMed ID: 2223019
    [No Abstract]   [Full Text] [Related]  

  • 22. The TE4D-Cog: a new test for detecting early dementia in English-speaking populations.
    Mahoney R; Johnston K; Katona C; Maxmin K; Livingston G
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1172-9. PubMed ID: 16315149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
    Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility and limitations of Addenbrooke's Cognitive Examination-Revised for detecting mild cognitive impairment in Parkinson's disease.
    Komadina NC; Terpening Z; Huang Y; Halliday GM; Naismith SL; Lewis SJ
    Dement Geriatr Cogn Disord; 2011; 31(5):349-57. PubMed ID: 21613789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Weigl Colour-Form Sorting Test: a quick and easily administered bedside screen for dementia and executive dysfunction.
    Hobson P; Meara J; Taylor C
    Int J Geriatr Psychiatry; 2007 Sep; 22(9):909-15. PubMed ID: 17245801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between cognitive dysfunction and behavioural symptoms in Nigerian patients with Parkinson's disease no dementia.
    Ojagbemi A
    J Parkinsons Dis; 2013 Jan; 3(3):293-300. PubMed ID: 23963316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pill questionnaire in a nondemented Parkinson's disease population.
    Reginold W; Armstrong MJ; Duff-Canning S; Lang A; Tang-Wai D; Fox S; Rothberg B; Zadikoff C; Kennedy N; Gill D; Eslinger P; Mapstone M; Chou K; Persad C; Litvan I; Mast B; Marras C
    Mov Disord; 2012 Sep; 27(10):1308-11. PubMed ID: 22865587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
    Goetz CG; Emre M; Dubois B
    Ann Neurol; 2008 Dec; 64 Suppl 2():S81-92. PubMed ID: 19127578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test.
    Claesson IM; Ytterberg C; Johansson S; Almkvist O; von Koch L
    Mult Scler; 2007 Mar; 13(2):272-4. PubMed ID: 17439898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale.
    Kulisevsky J; Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Campolongo A; García-Sánchez C; Pascual-Sedano B; Ribosa-Nogué R; Villa-Bonomo C
    Parkinsonism Relat Disord; 2013 Sep; 19(9):812-7. PubMed ID: 23773412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Audio Recorded Cognitive Screen (ARCS) in patients with multiple sclerosis: a practical tool for multiple sclerosis clinics.
    Lechner-Scott J; Kerr T; Spencer B; Agland S; Lydon A; Schofield PW
    Mult Scler; 2010 Sep; 16(9):1126-33. PubMed ID: 20621944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for Alzheimer's disease among illiterate elderly: accuracy analysis for multiple instruments.
    Aprahamian I; Martinelli JE; Cecato J; Yassuda MS
    J Alzheimers Dis; 2011; 26(2):221-9. PubMed ID: 21593559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SCOPA-cognition cutoff value for detection of Parkinson's disease dementia.
    Verbaan D; Jeukens-Visser M; Van Laar T; van Rooden SM; Van Zwet EW; Marinus J; van Hilten JJ
    Mov Disord; 2011 Aug; 26(10):1881-6. PubMed ID: 21542025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuropsychological evaluation in multiple sclerosis].
    Arnett P; Forn C
    Rev Neurol; 2007 Feb 1-15; 44(3):166-72. PubMed ID: 17285522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Parkinson disease and cognition].
    Kulisevsky J; Pascual-Sedano B
    Neurologia; 1999 May; 14 Suppl 1():72-81. PubMed ID: 10377731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive functioning in children with multiple sclerosis.
    Montiel-Nava C; Peña JA; González-Pernía S; Mora-La Cruz E
    Mult Scler; 2009 Feb; 15(2):266-8. PubMed ID: 18922833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do the ABCS 135 short cognitive screen and its subtests discriminate between normal cognition, mild cognitive impairment and dementia?
    Standish TI; Molloy DW; Cunje A; Lewis DL
    Int J Geriatr Psychiatry; 2007 Mar; 22(3):189-94. PubMed ID: 16977680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive screening in multiple sclerosis.
    Scherer P
    J Neurol; 2007 May; 254 Suppl 2():II26-9. PubMed ID: 17503125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.